EL
RDY icon

EWA LLC’s Dr. Reddy's Laboratories RDY Stock Holding History

EWA LLC’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,251
Closed -$142K – 345
2026
Q1 		$142K Sell
10,251
-2,214
-18% -$30.8K 0.03% 263
2025
Q4 		$175K Buy
12,465
+818
+7% +$11.5K 0.04% 240
2025
Q3 		$163K Buy
11,647
+408
+4% +$5.87K 0.05% 206
2025
Q2 		$169K Sell
11,239
-180
-2% -$2.57K 0.05% 193
2025
Q1 		$151K Buy
11,419
+414
+4% +$5.71K 0.06% 159
2024
Q4 		$174K Sell
11,005
-45,585
-81% -$685K 0.07% 141
2024
Q3 		$161K Buy
+56,590
New +$911K 0.06% 152

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

EWA LLC's RDY Position: Q2 2026 in Review

EWA LLC sold out of Dr. Reddy's Laboratories (RDY) in Q2 2026, closing a stake of 10,251 shares — an estimated $142K sold.

EWA LLC first reported a position in RDY in Q3 2024 and held it in 7 quarters. The position peaked at $175K in Q4 2025. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • EWA LLC reported no remaining Dr. Reddy's Laboratories position as of Q2 2026 after selling out during the quarter.
  • EWA LLC sold 10,251 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $142K.
  • EWA LLC first reported a position in Dr. Reddy's Laboratories in Q3 2024 and held it in 7 quarters.
  • EWA LLC's Dr. Reddy's Laboratories position peaked at $175K in Q4 2025.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on EWA LLC's 13F filing for Q2 2026, filed 14 Jul 2026.